Search research articles
Contact Us
Filters
Showing results (11-20 of 21) with videos related to
Page
of 3
Sort By:
Pediatric Blood & Cancer
|
February 13, 2008
Results in patients with cranial parameningeal sarcoma and metastases (Stage 4) treated on Intergroup Rhabdomyosarcoma Study Group (IRSG) Protocols II-IV, 1978-1997: report from the Children's Oncology Group
Beverly Raney, James Anderson, John Breneman, et al.
International Journal of Radiation Oncology, Biology, Physics
|
November 23, 2011
Local control with reduced-dose radiotherapy for low-risk rhabdomyosarcoma: a report from the Children's Oncology Group D9602 study
John Breneman, Jane Meza, Sarah S Donaldson, et al.
Pediatric Blood & Cancer
|
April 5, 2021
Rhabdomyosarcoma
Raphael L Yechieli, Henry C Mandeville, Susan M Hiniker, et al.
International Journal of Radiation Oncology, Biology, Physics
|
August 24, 2018
Treatment Approach and Outcomes in Infants With Localized Rhabdomyosarcoma: A Report From the Soft Tissue Sarcoma Committee of the Children's Oncology Group
Julie A Bradley, Mark L Kayton, Yueh-Yun Chi, et al.
International Journal of Cancer
|
June 12, 2020
Impact of local control and surgical lymph node evaluation in localized paratesticular rhabdomyosarcoma: A report from the Children's Oncology Group Soft Tissue Sarcoma Committee
Jonathan C Routh, Roshni Dasgupta, Yueh-Yun Chi, et al.
Pediatric Blood & Cancer
|
January 21, 2006
Asparagine depletion after pegylated E. coli asparaginase treatment and induction outcome in children with acute lymphoblastic leukemia in first bone marrow relapse: a Children's Oncology Group study (CCG-1941)
Mohammad Jarrar, Paul S Gaynon, Antonia P Periclou, et al.
JMIR Research Protocols
|
October 7, 2022
FLASH Radiotherapy for the Treatment of Symptomatic Bone Metastases (FAST-01): Protocol for the First Prospective Feasibility Study
Emily C Daugherty, Anthony Mascia, Yong Zhang, et al.
Pediatric Blood & Cancer
|
May 27, 2017
45 Gy is not sufficient radiotherapy dose for Group III orbital embryonal rhabdomyosarcoma after less than complete response to 12 weeks of ARST0331 chemotherapy: A report from the Soft Tissue Sarcoma Committee of the Children's Oncology Group
Ralph P Ermoian, John Breneman, David O Walterhouse, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|
June 24, 2026
FAST-02: Results from the second in-human prospective evaluation of single-fraction proton FLASH for symptomatic thoracic bone metastases
Emily C Daugherty, Yongbin Zhang, Zhiyan Xiao, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|
September 28, 2023
Factors associated with radiation necrosis and intracranial control in patients treated with immune checkpoint inhibitors and stereotactic radiotherapy
Jacob Hall, Kevin Lui, Xianming Tan, et al.
Page
of 3
Search research articles
Search
Showing results (11-20 of 21) with videos related to
Sort By:
Page
of 3
Pediatric Blood & Cancer
|
February 13, 2008
Results in patients with cranial parameningeal sarcoma and metastases (Stage 4) treated on Intergroup Rhabdomyosarcoma Study Group (IRSG) Protocols II-IV, 1978-1997: report from the Children's Oncology Group
Beverly Raney, James Anderson, John Breneman, et al.
International Journal of Radiation Oncology, Biology, Physics
|
November 23, 2011
Local control with reduced-dose radiotherapy for low-risk rhabdomyosarcoma: a report from the Children's Oncology Group D9602 study
John Breneman, Jane Meza, Sarah S Donaldson, et al.
Pediatric Blood & Cancer
|
April 5, 2021
Rhabdomyosarcoma
Raphael L Yechieli, Henry C Mandeville, Susan M Hiniker, et al.
International Journal of Radiation Oncology, Biology, Physics
|
August 24, 2018
Treatment Approach and Outcomes in Infants With Localized Rhabdomyosarcoma: A Report From the Soft Tissue Sarcoma Committee of the Children's Oncology Group
Julie A Bradley, Mark L Kayton, Yueh-Yun Chi, et al.
International Journal of Cancer
|
June 12, 2020
Impact of local control and surgical lymph node evaluation in localized paratesticular rhabdomyosarcoma: A report from the Children's Oncology Group Soft Tissue Sarcoma Committee
Jonathan C Routh, Roshni Dasgupta, Yueh-Yun Chi, et al.
Pediatric Blood & Cancer
|
January 21, 2006
Asparagine depletion after pegylated E. coli asparaginase treatment and induction outcome in children with acute lymphoblastic leukemia in first bone marrow relapse: a Children's Oncology Group study (CCG-1941)
Mohammad Jarrar, Paul S Gaynon, Antonia P Periclou, et al.
JMIR Research Protocols
|
October 7, 2022
FLASH Radiotherapy for the Treatment of Symptomatic Bone Metastases (FAST-01): Protocol for the First Prospective Feasibility Study
Emily C Daugherty, Anthony Mascia, Yong Zhang, et al.
Pediatric Blood & Cancer
|
May 27, 2017
45 Gy is not sufficient radiotherapy dose for Group III orbital embryonal rhabdomyosarcoma after less than complete response to 12 weeks of ARST0331 chemotherapy: A report from the Soft Tissue Sarcoma Committee of the Children's Oncology Group
Ralph P Ermoian, John Breneman, David O Walterhouse, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|
June 24, 2026
FAST-02: Results from the second in-human prospective evaluation of single-fraction proton FLASH for symptomatic thoracic bone metastases
Emily C Daugherty, Yongbin Zhang, Zhiyan Xiao, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|
September 28, 2023
Factors associated with radiation necrosis and intracranial control in patients treated with immune checkpoint inhibitors and stereotactic radiotherapy
Jacob Hall, Kevin Lui, Xianming Tan, et al.
Page
of 3